Last update: May 1, 2016
Minimal risk for breastfeeding and infant.
Antibacterial glycopeptide drug.
A high molecular weight its a reason to be excreted in clinically non-significant amount into breast milk, much lower than the dose commonly used for infection in newborns and infants.
Its low oral bioavailability hinders the passage toward infant’s plasma from ingested mother’s milk, except in preterm infants and immediate neonatal period, in which the infant may have an increased intestinal permeability.
Take into account the possibility of negative results of bacterial cultures from febrile infants when their mothers are receiving antibiotics.
We do not have alternatives for Vancomycin since it is relatively safe.
Suggestions made at e-lactancia are done by APILAM´s pediatricians and pharmacists, and are based on updated scientific publications.
It is not intended to replace the relationship you have with your doctor but to compound it.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine from United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM